https://www.selleckchem.com/pr....oducts/a-1210477.htm
BDNF, GABA and β-endorphin were identified as potential molecular markers of rTMS and warrant further exploration. This study, which is the first systematic review to examine molecular markers of rTMS in both neurological and psychiatric disorders, provides an updated review of this subject and highlight the need for more placebo-controlled and adequately powered studies to identify biomarkers of rTMS. This study, which is the first systematic review to examine molecular markers of rTMS in both neurological and psychiatric disorders,
Like
Comment
Share
